Evidence-Based Reviews
Evidence-Based Reviews
Telepsychiatry: What you need to know
Evidence suggests that this tool is effective, cost-efficient, and well-accepted.
Evidence-Based Reviews
Cannabidiol for psychosis: A review of 4 studies
Some early research suggests CBD might be beneficial for patients with psychosis, but evidence is mixed.
Evidence-Based Reviews
Time to retire haloperidol?
For emergency agitation, evidence suggests newer alternatives may be a better choice.
Reviews
Does your patient have the right to refuse medications?
A brief guide to the legal aspects of administering involuntary medications.
Evidence-Based Reviews
Second-generation long-acting injectable antipsychotics: A practical guide
Understanding each of these medications’ unique properties can optimize patient care.
Evidence-Based Reviews
Kratom: What we know, what to tell your patients
Educate patients about the risks of this increasingly popular but unregulated substance.
Evidence-Based Reviews
Opioid use disorder in adolescents: An overview
Treatment needs to include interventions that address young patients’ unique needs.
Evidence-Based Reviews
Top research findings of 2018-2019 for clinical practice
Second of 2 parts. These studies may change how you treat schizophrenia, MDD, alcohol use disorder, more.
Evidence-Based Reviews
Antipsychotics, dopamine, and pain
These medications’ effects on dopamine might help address chronic pain.
Evidence-Based Reviews
Buspirone: A forgotten friend
This older medication offers several advantages when treating anxiety or depression.
Evidence-Based Reviews
Top research findings of 2018-2019 for clinical practice
First of 2 parts. These studies may change your approach to treatment-resistant depression, PTSD, and more.